Clinical pharmacokinetics of enoxacin in subjects with renal or hepatic impairment.
Novelli
A
A
Department of Preclinical and Clinical Pharmacology, University of Florence, Italy.
Reali
E F
EF
Amato
M
M
Dami
A
A
Fallani
S
S
Periti
P
P
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics; D003404:Creatinine / Q000378:metabolism; D015365:Enoxacin / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000378:metabolism*; D007700:Kinetics; D008103:Liver Cirrhosis / Q000378:metabolism; D008107:Liver Diseases / Q000378:metabolism*; D008297:Male; D008657:Metabolic Clearance Rate; D012016:Reference Values
D000900:Anti-Bacterial Agents; D015365:Enoxacin; D003404:Creatinine